Prior to co-founding C3 Research in 2008, Ron held various positions in academic institutions, large pharma and biotechnology companies. He has over 25 years of clinical operations experience focused primarily on oncology, neurology, women’s health, hematology and clinical pharmacology studies. At C3 Ron is responsible for leading C3 Research’s business and clinical operations as well as growing its brand and geographic reach. Ron plays an instrumental role in designing and implementing a vision and strategic direction that has resulted in C3 Research emerging as a reputable and quality driven performance CRO. Ron has made significant contributions to nearly a hundred studies spanning a broad therapeutic range and phase of development and has played an integral role supporting numerous FDA approvals.